Abstract
Enteric-coated guar gum microspheres of ornidazole aimed for colon drug delivery have been developed. The influence of core to coat ratio was investigated upon the encapsulation efficiency, swelling, weight loss and drug release behavior. The SEM was used to characterize the surface of these microspheres. Drug–polymer interactions were studied by differential scanning calorimetry and X-ray diffractometry. Enteric coating with Eudragit® S100 enabled maintenance of microspheres integrity until its expected arrival to colon. The in vitro drug release was investigated using USP dissolution rate test paddle type apparatus in different simulated mediums. Only 10 % of drug was release after 5 h while after 8 h (in PBS pH 7.5) a significant increase in percent cumulative drug release (85 %) was observed. In medium containing rat cecal content (pH 7.0) i.e. the amount of the drug released from the formulation was found to be 68 % and ~ 78.3 % with 2 % and 4% w/v cecal matter. Drug release in presence of culture of Bacteriodes ovatus was found to be 77 %. Ornidazole release kinetics corresponds best to zero order model and drug release mechanism was diffusion and swelling controlled. The significance of differences was evaluated by analysis of variance (ANOVA). Differences were considered statistically significant at P < 0.05.
Keywords: Enteric coating, ornidazole, guar gum, eudragit® S100, microspheres, rat cecal contents, bacterial culture, DSC, XRD
Current Nanoscience
Title:Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery
Volume: 8 Issue: 4
Author(s): Raj Kumar Shukla, Suman Ramteke, Piyush Trivedi and Akanksha Tiwari
Affiliation:
Keywords: Enteric coating, ornidazole, guar gum, eudragit® S100, microspheres, rat cecal contents, bacterial culture, DSC, XRD
Abstract: Enteric-coated guar gum microspheres of ornidazole aimed for colon drug delivery have been developed. The influence of core to coat ratio was investigated upon the encapsulation efficiency, swelling, weight loss and drug release behavior. The SEM was used to characterize the surface of these microspheres. Drug–polymer interactions were studied by differential scanning calorimetry and X-ray diffractometry. Enteric coating with Eudragit® S100 enabled maintenance of microspheres integrity until its expected arrival to colon. The in vitro drug release was investigated using USP dissolution rate test paddle type apparatus in different simulated mediums. Only 10 % of drug was release after 5 h while after 8 h (in PBS pH 7.5) a significant increase in percent cumulative drug release (85 %) was observed. In medium containing rat cecal content (pH 7.0) i.e. the amount of the drug released from the formulation was found to be 68 % and ~ 78.3 % with 2 % and 4% w/v cecal matter. Drug release in presence of culture of Bacteriodes ovatus was found to be 77 %. Ornidazole release kinetics corresponds best to zero order model and drug release mechanism was diffusion and swelling controlled. The significance of differences was evaluated by analysis of variance (ANOVA). Differences were considered statistically significant at P < 0.05.
Export Options
About this article
Cite this article as:
Kumar Shukla Raj, Ramteke Suman, Trivedi Piyush and Tiwari Akanksha, Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery, Current Nanoscience 2012; 8 (4) . https://dx.doi.org/10.2174/157341312801784186
DOI https://dx.doi.org/10.2174/157341312801784186 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondria and Familial Predisposition to Breast Cancer
Current Genomics Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: The Human Microbiome - A Therapeutic Target for Prevention and Treatment of Chronic Disease (Executive Editor: Kieran Tuohy)]
Current Pharmaceutical Design Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues
Current Drug Metabolism Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets Polymers and Drug Delivery Systems
Current Drug Delivery Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry The Regulation of miRNAs in Inflammation-Related Carcinogenesis
Current Pharmaceutical Design Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance
Current Medicinal Chemistry Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Current Pharmaceutical Design Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer
Current Pharmaceutical Design Anti-IL-12/23 in Crohn's Disease: Bench and Bedside
Current Drug Targets Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets Natural Products as Exquisitely Potent Cytotoxic Payloads for Antibody- Drug Conjugates
Current Topics in Medicinal Chemistry Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments
Current Clinical Pharmacology Editorial [Targeting Genetic Instability in Cancer Cells (Guest Editor: Francesco Colotta)]
Current Drug Targets Physiology, Pharmacology and Pathophysiology of the pH Regulatory Transport Proteins NHE1 and NBCn1: Similarities, Differences, and Implications for Cancer Therapy
Current Pharmaceutical Design Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets